RSLS 13G/A Filing: 80-Share Position, 0.003% Ownership
Rhea-AI Filing Summary
ReShape Lifesciences Schedule 13G/A discloses that Ayrton Capital LLC, Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, and Waqas Khatri each report beneficial ownership of 80 shares of common stock of the issuer. The 80-share position is described as 8 shares held plus 72 shares issuable on exercise of warrants, and the warrant-related issuable shares are subject to a 9.99% beneficial ownership blocker. The holdings are reported as of June 30, 2025.
The filing uses a class base of 2,385,960 shares (1,331,356 outstanding plus 1,054,604 shares sold in a recent offering) and reports that each reporting person represents 0.003% of the class. The reporting parties include a Cayman Islands fund managed by Ayrton Capital and Waqas Khatri as managing member; signatures certify the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small disclosed position — 80 shares (0.003%), mainly warrant exposure; filing is informational and not material to control.
The filing reports identical beneficial ownership across three related reporting persons: 80 shares each, comprised of 8 shares held and 72 shares issuable on warrants. The reported percentage of 0.003% is calculated on a class base of 2,385,960 shares. The presence of a 9.99% beneficial ownership blocker on the warrants is noted. From a securities-impact perspective this disclosure documents positions but does not reflect a material ownership stake or trigger reporting thresholds that typically affect market perception or control.
TL;DR: Filing documents ownership and ordinary-course acquisition; it contains no signs of a challenge to governance or control intent.
The statement includes representations that the securities were acquired and are held in the ordinary course of business and not to influence control. Signatories include the investment manager and the managing member, and the report identifies the Cayman fund and its Delaware investment manager. Given the reported 0.003% ownership and the limited share count, the disclosure is routine from a governance standpoint and does not indicate activism or control efforts.
FAQ
Does the filing indicate an intent to influence control of RSLS?
What class of security and CUSIP are reported in this filing for RSLS?
AI-generated analysis. How Rhea-AI works. Not financial advice.